The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.00
Bid: 328.50
Ask: 330.50
Change: -7.50 (-2.24%)
Spread: 2.00 (0.609%)
Open: 329.00
High: 332.50
Low: 321.00
Prev. Close: 334.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: DFS Furniture gains share of weak market

Thu, 21st Sep 2023 09:40

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

----------

SMALL-CAP - WINNERS

----------

DFS Furniture PLC, up 4.9% 112.45p, 12-month range 101p-170p. The sofa retailer continues to win UK market share in a "very tough market" during its financial year, which ended on June 25, and outlines a path to improving margins. DFS says revenue from continuing operations fell 5.2% year-on-year to GBP1.09 billion from GBP1.15 billion, as pretax profit slumps 49% to GBP29.7 million from GBP58.5 million. Underlying profit before tax and brand amortisation is GBP30.6 million, which is in line with its interim guidance. DFS expects underlying profit before tax and brand amortisation to improve by a low single-digit percentage in financial 2024 to a GBP30 million to GBP35 million range. This assumes market volumes fall 5%, DFS notes. "We are confident the market will recover; however we can't predict how quickly that will happen. We have a clear route to a 5% [profit before tax] margin without market recovery, supported by further margin improvement, new cost efficiencies, and continued growth in Home," DFS says.

----------

Oxford BioMedica PLC, up 5.4% at 283.50 pence, 12-month range 236.50-575.00p. The cell and gene therapy company adds to Wednesday's gains after it announced exclusive talks with Institut Meriueux SA about buying ABL Europe, a pure-play European contract development and manufacturing organization. As part of the deal, Institut Merieux would become one of its major shareholders. The stock is down 16% over the past month however.

----------

SMALL-CAP - LOSERS

----------

James Fisher & Sons PLC, down 2.5% at 345.14p, 12-month range 241p-427.5p. The marine services swings to a pretax loss in the first half of 2023 of GBP4.4 million from a profit of GBP5.2 million a year before. This comes despite revenue rising 17% GBP252.0 million from GBP215.0 million. The loss is due to GBP9.3 million in refinancing legal and advisory costs, as well as higher interest rates, offsetting a positive operating performance, James Fisher explains. "All three divisions delivered revenue and profit growth against the first half of 2022, with a particularly strong increase seen in the Energy division," says CEO Jean Vernet. Trading in July and August is in line with its expectations, and James Fisher leaves its full-year expectations unchanged.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
27 Jul 2020 08:13

LONDON BRIEFING: Ryanair Expect 60% Drop In Passengers In Current Year

LONDON BRIEFING: Ryanair Expect 60% Drop In Passengers In Current Year

Read more
15 Jul 2020 11:42

AstraZeneca Covid-19 vaccine shows promise - report

(Sharecast News) - A Covid-19 vaccine backed by AstraZeneca is producing positive results in initial trials, according to a report.

Read more
2 Jul 2020 17:54

DIRECTOR DEALINGS: Oxford Biomedica Director's Associate Buys Shares

DIRECTOR DEALINGS: Oxford Biomedica Director's Associate Buys Shares

Read more
24 Jun 2020 15:21

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

Read more
19 Jun 2020 14:40

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

Read more
18 Jun 2020 18:26

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Read more
8 Jun 2020 17:12

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Read more
8 Jun 2020 11:54

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

Read more
8 Jun 2020 09:41

UPDATE 2-UK stocks end lower on concerns over corporate debt; AstraZeneca weighs

* AstraZeneca slips on report of potential merger with Gilead* Plus500 falls after big revenue hit from client trading wins* Oil & gas stocks gain after OPEC production cuts* BP rises after report of job cuts (Adds details, updates to close)By Shr...

Read more
3 Jun 2020 17:28

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

Read more
1 Jun 2020 12:02

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

Read more
1 Jun 2020 07:43

UPDATE 2-AstraZeneca scores twin drug approvals alongside vaccine progress

* Lynparza gains CHMP nod for advanced pancreatic cancer* Brilinta approved by FDA to cut risk of first heart attack* Coronavirus vaccine partner Oxford Biomedica appoints new chair (Writes through, adds detail, context)June 1 (Reuters) - Britain's...

Read more
28 May 2020 12:41

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Read more
14 May 2020 09:19

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

Read more
6 May 2020 15:07

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.